PH24473A - The use of ethylene oxide/propylene oxide block copolymers for controlling foam in liquid pharmaceutical formulations - Google Patents

The use of ethylene oxide/propylene oxide block copolymers for controlling foam in liquid pharmaceutical formulations

Info

Publication number
PH24473A
PH24473A PH35316A PH35316A PH24473A PH 24473 A PH24473 A PH 24473A PH 35316 A PH35316 A PH 35316A PH 35316 A PH35316 A PH 35316A PH 24473 A PH24473 A PH 24473A
Authority
PH
Philippines
Prior art keywords
block copolymers
liquid pharmaceutical
pharmaceutical formulations
ethylene oxide
propylene oxide
Prior art date
Application number
PH35316A
Inventor
Karl-Detlev Schwabe
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of PH24473A publication Critical patent/PH24473A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Professional, Industrial, Or Sporting Protective Garments (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Jib Cranes (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Polyethers (AREA)

Abstract

There is described the use of ethylene oxide/propylene oxide block copolymers in the control of foam in pharmaceutical preparations, in particular those for parenteral application, and furthermore liquid pharmaceutical preparations and their production.
PH35316A 1986-05-30 1987-05-28 The use of ethylene oxide/propylene oxide block copolymers for controlling foam in liquid pharmaceutical formulations PH24473A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3618217A DE3618217C1 (en) 1986-05-30 1986-05-30 Use of ethylene oxide-propylene oxide block polymers for foam control in liquid medicinal preparations

Publications (1)

Publication Number Publication Date
PH24473A true PH24473A (en) 1990-07-18

Family

ID=6301946

Family Applications (1)

Application Number Title Priority Date Filing Date
PH35316A PH24473A (en) 1986-05-30 1987-05-28 The use of ethylene oxide/propylene oxide block copolymers for controlling foam in liquid pharmaceutical formulations

Country Status (24)

Country Link
EP (1) EP0247584B1 (en)
JP (1) JPS62289529A (en)
KR (1) KR970005334B1 (en)
AT (1) ATE59783T1 (en)
AU (1) AU599658B2 (en)
CA (1) CA1322170C (en)
CS (1) CS268831B2 (en)
DD (1) DD266026A5 (en)
DE (2) DE3618217C1 (en)
DK (1) DK167211B1 (en)
ES (1) ES2036544T3 (en)
FI (1) FI88871C (en)
GR (1) GR3001614T3 (en)
HK (1) HK86895A (en)
HU (1) HU196311B (en)
IE (1) IE60658B1 (en)
IL (1) IL82700A (en)
MA (1) MA20988A1 (en)
MY (1) MY102448A (en)
NO (1) NO175844C (en)
NZ (1) NZ220479A (en)
PH (1) PH24473A (en)
PT (1) PT84970B (en)
ZA (1) ZA873878B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1475098B1 (en) * 2002-01-18 2015-08-05 Asahi Kasei Pharma Corporation High-concentration preparation of soluble thrombomodulin
DE102010048948A1 (en) 2010-10-19 2011-12-29 Clariant International Ltd. Aqueous defoamer emulsion, useful e.g. as protective colloids, comprises oil phase, emulsifiers, and water-soluble or -swellable, crosslinked copolymers containing e.g. acrylamidoalkylsulfonic acid- and cyclic N-vinylcarboxamide-compounds
DE102018220624A1 (en) 2018-11-29 2020-06-04 B. Braun Melsungen Ag Aqueous composition, especially for the treatment of mucous membranes and / or wounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3142628A (en) * 1964-07-28 Process of reducing foam in submerges
DE925375C (en) * 1949-08-03 1955-03-21 Upjohn Co Process for the production of a procaine-penicillin-G preparation
US2937104A (en) * 1958-08-18 1960-05-17 Stephan John Thomas Polymeric alkylene-oxide defoamer material for alkaline aqueous adhesive solutions and the like
JPS5416568B2 (en) * 1972-09-29 1979-06-23
US4104033A (en) * 1975-09-12 1978-08-01 Drew Chemical Corporation Foam prevention in sodium carbonate crystallization
GB2067533B (en) * 1980-01-15 1983-07-13 Exxon Research Engineering Co Defoaming acid gas scrubbing solutions
US4533542A (en) * 1983-08-22 1985-08-06 Eli Lilly And Company Pharmaceutical compositions for storage in plastic containers and process therefor

Also Published As

Publication number Publication date
AU7364387A (en) 1987-12-03
IE871429L (en) 1987-11-30
DK274787A (en) 1987-12-01
CA1322170C (en) 1993-09-14
DE3618217C1 (en) 1987-08-06
HU196311B (en) 1988-11-28
ES2036544T3 (en) 1993-06-01
PT84970B (en) 1990-02-08
JPS62289529A (en) 1987-12-16
NO175844C (en) 1994-12-21
CS268831B2 (en) 1990-04-11
FI872381A0 (en) 1987-05-28
FI872381L (en) 1987-12-01
NO872265D0 (en) 1987-05-29
KR970005334B1 (en) 1997-04-15
IE60658B1 (en) 1994-08-10
NZ220479A (en) 1989-03-29
EP0247584A2 (en) 1987-12-02
EP0247584A3 (en) 1988-10-12
DD266026A5 (en) 1989-03-22
FI88871B (en) 1993-04-15
FI88871C (en) 1993-07-26
DK167211B1 (en) 1993-09-20
GR3001614T3 (en) 1992-11-23
IL82700A (en) 1991-06-10
IL82700A0 (en) 1987-11-30
DK274787D0 (en) 1987-05-29
HK86895A (en) 1995-06-09
NO872265L (en) 1987-12-01
NO175844B (en) 1994-09-12
MY102448A (en) 1992-06-30
HUT44179A (en) 1988-02-29
AU599658B2 (en) 1990-07-26
KR870010873A (en) 1987-12-18
DE3767215D1 (en) 1991-02-14
EP0247584B1 (en) 1991-01-09
ZA873878B (en) 1988-01-27
ATE59783T1 (en) 1991-01-15
CS389387A2 (en) 1989-08-14
MA20988A1 (en) 1987-12-31
PT84970A (en) 1987-06-01

Similar Documents

Publication Publication Date Title
PH31617A (en) Novel thienylcarboxylates of amino alcohols, theirquaternary products and use of these compounds.
AU5330286A (en) Modified tissue-type plasminogen activator
EP0276543A3 (en) Use of buspirone for the improvement of short term memory
AU7042187A (en) 2-azolylmethyl-2-aryl-1, 3-dioxolanes and the salts thereof,processes for the preparation thereof,agents containing same,and the use thereof
IL82272A0 (en) Tissue-type plasminogen activator and process for preparation thereof
AU8309387A (en) Novel plasminogen activators
AU7090687A (en) Modified tissue-type plasminogen activators
EP0262987A3 (en) Catalysts for the preparation of elastomeric, olefin copolymers, and copolymers obtained using them
PH24473A (en) The use of ethylene oxide/propylene oxide block copolymers for controlling foam in liquid pharmaceutical formulations
EP0266993A3 (en) Method and therapeutic compositions for the treatment of bleeding disorders
DE3665541D1 (en) Silicone-alkylene oxide copolymers as foam control agents in ultrafiltration processes
AR242598A1 (en) Plastic copolymers of propylene with linear dienes and the procedure for the preparation of these copolymers.
AU602681B2 (en) Modified plasminogen activators
HU901384D0 (en) Antidotes comprising substituted 1,8-naphthyridines and process for preparations of the active ingredients
EP0270782A3 (en) Therapeutic agents for the prophylaxis of tumour metastasis
AU7042387A (en) 2-azolylmethyl-2-aryl-1, 3-dioxolanes and the salts thereof, processes for the preparation thereof, agents containing same, and the use thereof
AU613510B2 (en) Use of zofenopril for the treatment of rheumatoid arthritis
MTP1002B (en) For the use of ethylene oxide propylene oxide block copolymers for controlling foam in liquid pharmaceutical formulations,and a process for their preparation
AU7090787A (en) Tissue plasminogen activator
AU5140490A (en) Use of mixed micelles
AU3780089A (en) Shaped mixed oxide products
AU587293B2 (en) 5-heterocyclic-2,4-dialkyl-3H-1,2,4-triazole-3-thiones and their use as antidepressants
AU7696087A (en) Recombinant human tissue plasminogen activator composition
AU609337B2 (en) Tissue plasminogen activator (t-pa) muteins and processes for the preparation thereof
IE873439L (en) Copolymers of ethylene and 1,3-butadiene